D. Berthod

Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE.

D. Vernerey, G. Mouillet, A. Thiery-Vuillemin, 2020, Bulletin du cancer.

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol

D. Vernerey, F. Bonnetain, G. Mouillet, 2019, Health and Quality of Life Outcomes.

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial

D. Vernerey, M. Paillard, G. Mouillet, 2018, Trials.